BioMedical

Mark Anderson (2012) examines the drafting and negotiation of CTAs. He addresses key issues like regulatory compliance, intellectual property rights, liability, and indemnities, providing practical guidance on balancing stakeholder interests, ensuring clarity, and managing risks in clinical trial…

Mark Anderson (2009) provides detailed guidance on drafting and negotiating CTAs. He covers regulatory compliance, intellectual property, liability, and indemnities, emphasising clear contractual terms to balance stakeholder interests and navigate legal complexities effectively.

Joris Swennen and Sander Van Loock (2013) analyse key challenges in forming consortia. They address IP ownership, co-ownership, background access, and publication, emphasising clear communication, legal certainty, and tailored agreements to balance academic and industry interests effectively.